BalancerBAL Rank #403 |
ATH 96.7% 04 May 2021 1.1%
- 24hr 1.1%
- 7d 10.2%
- 14d 10.7%
- 30d 28.6%
- 60d 21.0%
- 200d 29.3%
- 1y 34.5%
Announcements
- Circulating Supply60.96M
- Total Supply65.99M
- Max Supply96.15M
- Fully Diluted Valuation$164.75M
- Market Cap$152.19M
- Rank#403
- Price $2.50
- Trading Volume $19.89M
- 24Hr Low/High$2.45 / $2.61
- Powered by Coingecko
Balancer is currently trading at a price of USD $2.50 with a 24-hour trading volume of $19.89M. In the past 24 hours the price of Balancer is $0.0274. With a circulating supply of 60.96M from a total supply of 65.99M.
Ethereum 0xba100000625a375442... | ||
Harmony Shard 0 0xdc5f76104d0b8d2bf2... | ||
Xdai 0x7ef541e2a220580489... | ||
Polygon Zkevm 0x120ef59b80774f0221... | ||
Optimistic Ethereum 0xfe8b128ba8c78aabc5... | ||
Base 0x4158734d47fc969217... | ||
Huobi Token 0x045de15ca76e76426e... | ||
Polygon Pos 0x9a71012b13ca4d3d0c... | ||
Arbitrum One 0x040d1edc9569d4bab2... | ||
Avalanche 0xe15bcb9e0ea69e6ab9... | ||
Energi 0x9b817c6e9a38e60460... |
Balancer is a non-custodial portfolio manager, liquidity provider, and price sensor The Balancer Protocol Governance Token (BAL) are distributed to Liquidity Providers of Balancer. BALs are a key way of decentralizing the governance of the protocol such that it can remain resilient over time, protected from the failure of any single stakeholder. The proposed amount of distributed BALs to liquidity providers is 145,000 per week, or approximately 7.5M per year. This means in the first year of BAL’s existence there would be 30% supply inflation off the initially allocated supply of 25M tokens. This high rate of supply inflation is meant to kickstart the distribution of governance rights of the protocol out to those who earn it.
- Country of Originn/a
- Genesis Date n/a
- Platform Ethereum
- Hashing Algorithm n/a
- Block Timen/a
Fair Liquidity
Unknown Liquidity (not enough data available)
* Anomaly - Trading price is an outlier against the average
** Inactive - No trades in the last 3 hours
No news from Balancer